BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Insteel Industries
IIIN
$625M
| $62.3M | ﹤0.01% |
2,901,058
+155,089
| +6% | +$3.28M |
|
|
IMGN
2227
DELISTED
Immunogen Inc
IMGN
| $62.2M | ﹤0.01% |
12,181,989
+89,552
| +0.7% | +$304K |
|
2228
NextCure
NXTC
$26.7M
| $62.1M | ﹤0.01% |
91,851
+71,879
| +360% | +$36.1M |
|
2229
MPLX
MPLX
$59.7B
| $62.1M | ﹤0.01% |
2,438,157
+117,734
| +5% | +$3M |
|
|
BZUN
2230
Baozun
BZUN
$172M
| $61.9M | ﹤0.01% |
1,868,364
-318,271
| -15% | -$12.6M |
|
2231
Pacific Biosciences
PACB
$368M
| $61.9M | ﹤0.01% |
12,033,320
+189,902
| +2% | +$965K |
|
|
SWAV
2232
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $61.7M | ﹤0.01% |
1,405,870
+983,147
| +233% | +$36.3M |
|
2233
Cato Corp
CATO
$66.1M
| $61.7M | ﹤0.01% |
3,546,735
+160,731
| +5% | +$2.88M |
|
2234
CALL
NXP Semiconductors
NXPI
$60.4B
| $61.7M | ﹤0.01% |
+484,500
| New | +$56.2M |
|
2235
Travere Therapeutics
TVTX
$5.78B
| $61.7M | ﹤0.01% |
4,341,899
+404,206
| +10% | +$5.16M |
|
|
CFXA
2236
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $61.6M | ﹤0.01% |
390,256
+25,824
| +7% | +$3.72M |
|
2237
CALL
SLB Ltd
SLB
$75B
| $61.1M | ﹤0.01% |
+1,520,000
| New | +$54.3M |
|
2238
CALL
Walt Disney
DIS
$181B
| $60.6M | ﹤0.01% |
419,000
+256,500
| +158% | +$35.8M |
|
2239
CNA Financial
CNA
$14.1B
| $60.6M | ﹤0.01% |
1,351,498
+209,488
| +18% | +$9.46M |
|
2240
SFL Corp
SFL
$1.61B
| $60.5M | ﹤0.01% |
4,160,529
+20,244
| +0.5% | +$293K |
|
|
CCF
2241
DELISTED
Chase Corporation
CCF
| $60.2M | ﹤0.01% |
507,772
+4,085
| +0.8% | +$474K |
|
|
EFC
2242
Ellington Financial
EFC
$1.71B
| $60M | ﹤0.01% |
3,273,830
+30,740
| +0.9% | +$562K |
|
2243
Rocket Pharmaceuticals
RCKT
$394M
| $60M | ﹤0.01% |
2,636,276
+18,236
| +0.7% | +$305K |
|
2244
Haverty Furniture Companies
HVT
$454M
| $59.9M | ﹤0.01% |
2,971,542
+101,910
| +4% | +$2.06M |
|
2245
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.74B
| $59.9M | ﹤0.01% |
1,251,875
+34,808
| +3% | +$1.63M |
|
|
RVNC
2246
DELISTED
Revance Therapeutics, Inc.
RVNC
| $59.9M | ﹤0.01% |
3,688,657
+122,686
| +3% | +$1.9M |
|
2247
Hyster-Yale Materials Handling
HY
$665M
| $59.8M | ﹤0.01% |
1,014,927
+6,532
| +0.6% | +$363K |
|
2248
America's Car Mart
CRMT
$26.9M
| $59.8M | ﹤0.01% |
545,394
-5,325
| -1% | -$515K |
|
|
CNR
2249
Core Natural Resources Inc
CNR
$4.45B
| $59.7M | ﹤0.01% |
4,113,463
+40,879
| +1% | +$564K |
|
2250
Cemex
CX
$16.3B
| $59.5M | ﹤0.01% |
15,747,205
+3,319,972
| +27% | +$12.6M |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.